Active, Not Recruiting
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT04442022
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- The Oncology Institute (TOI) Clinical Research Cerritos, California, United States
- Norton Cancer Institute, St. Matthews Louisville, Kentucky, United States